Journal of Cystic Fibrosis 2014
5 papers
The 2014 edition of the *Journal of Cystic Fibrosis* highlighted advancements in therapeutic monitoring and targeted treatment strategies. Research themes included the use of hyperpolarized helium-3 MRI to evaluate the effects of ivacaftor on lung ventilation in patients with the G551D-CFTR mutation. Clinical trials also investigated alternative delivery methods for existing treatments, such as the sinonasal inhalation of dornase alfa using vibrating aerosols, and documented specific approaches to eradicating *Pseudomonas aeruginosa* from the respiratory tract.
Beyond clinical interventions, the journal published work on the three-dimensional structural modeling of the CFTR protein to aid in the development of pharmacological correctors. Metabolic research was also represented, with studies utilizing the disposition index to identify beta-cell dysfunction in patients who otherwise maintained normal glucose tolerance. Prolific contributors to the year's volume included Jochen G. Mainz, Deborah Froh, and John P. Mugler. These publications reflect a trend toward combining molecular insights with refined diagnostic techniques to address both the respiratory and systemic manifestations of cystic fibrosis.
Top Authors
| Author | Papers |
|---|---|
| Brice Hoffmann | 1 |